| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/1997 | EP0753055A1 Enzymatic antimicrobial compositions |
| 01/15/1997 | EP0753054A1 Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections |
| 01/15/1997 | EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use |
| 01/15/1997 | EP0753013A1 Neurotrophin-6: a new member of the neurotrophin family |
| 01/15/1997 | EP0753010A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 01/15/1997 | EP0753009A1 Malaria peptides |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0752997A1 Novel cationic phospholipids for transfection |
| 01/15/1997 | EP0752888A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
| 01/15/1997 | EP0752887A1 Immunodeficiency recombinant poxvirus |
| 01/15/1997 | EP0752884A1 Method of treating auto-immune diseases using type one interferons |
| 01/15/1997 | EP0752882A1 Treatment for juvenile diabetes |
| 01/15/1997 | EP0752878A1 Products comprising substrates capable of enzymatic cross-linking |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752853A1 Human brain phosphodiesterase |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0752816A1 Nematicidal proteins |
| 01/15/1997 | EP0736106A4 Methods of screening for beta-amyloid peptide production inhibitors |
| 01/15/1997 | EP0644945A4 Pretreatment of microprojectiles prior to using in a particle gun. |
| 01/15/1997 | EP0641390B1 Chemical method for the analysis of dna sequences |
| 01/15/1997 | EP0625986B1 Oligothionucleotides |
| 01/15/1997 | EP0617737B1 Method for selecting recombinant micro-organisms of which the surface comprises at least one molecule having enzymatic activity |
| 01/15/1997 | EP0550592B1 Screening assays |
| 01/15/1997 | EP0530283B1 Method and means to perform biochemical reactions |
| 01/15/1997 | EP0504278B1 A new method for detecting a specific nucleic acid sequence in a sample of cells |
| 01/15/1997 | EP0491930B1 Primate lentivirus vaccines |
| 01/15/1997 | EP0464067B1 Solid phase diagnosis of medical conditions |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1140201A Autonomously replicating vector for construction of recombinant adenovirus concomitant virus packaging system and use thereof |
| 01/15/1997 | CN1033810C Process for enzymatic preparation of basic fibroblast growth factor |
| 01/14/1997 | US5594546 Diamond anvil cell for spectroscopic investigation of materials at high temperature, high pressure and shear |
| 01/14/1997 | US5594136 Useful in the separation of neutral and anionic species, phosphate ester hydrolysis, magnetic resonance imaging and photodynamic therapy |
| 01/14/1997 | US5594123 Oligonucleotide primers which hybridize with conserved regions of the nucleic acid sequences of the aids virus, for polymerase chain reactions |
| 01/14/1997 | US5594122 Bind to conserved regions of human immunodeficiency virus genetic material to prevent expression thereof |
| 01/14/1997 | US5594120 Integrin alpha subunit |
| 01/14/1997 | US5594119 Gene encoding carboxypeptidase of aspergillus niger |
| 01/14/1997 | US5594116 Inoculating an avian; isolating immunoglobulins; binding to affinity matrix; elution |
| 01/14/1997 | US5594115 Fusion protein containing polypeptides and metal chelating peptide |
| 01/14/1997 | US5594114 Schwann cell mitogenic factor, its preparation and use |
| 01/14/1997 | US5594108 Schizophrenia |
| 01/14/1997 | US5594107 Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
| 01/14/1997 | US5594105 Peptide inhibitors of mitogenesis and motogenesis |
| 01/14/1997 | US5594103 Lantibiotics similar to nisin a |
| 01/14/1997 | US5594101 Anti-obesity proteins |
| 01/14/1997 | US5594032 Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
| 01/14/1997 | US5593974 Localized oligonucleotide therapy |
| 01/14/1997 | US5593972 Genetic immunization |
| 01/14/1997 | US5593963 Expression of phytase in plants |
| 01/14/1997 | US5593959 Anticoagulants |
| 01/14/1997 | US5593887 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| 01/14/1997 | US5593885 Phage defense rotation strategy |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593883 Ancient microorganisms |
| 01/14/1997 | US5593882 Selectin variants |
| 01/14/1997 | US5593881 Bacillus thuringiensis delta-endotoxin |
| 01/14/1997 | US5593879 Cell death genes of Drosophila melanogaster and vertebrate analogs |
| 01/14/1997 | US5593878 Recombinant phospholipase A2 enzyme |
| 01/14/1997 | US5593877 Nucleic acid and recombinant production of vespid venom hyaluronidase |
| 01/14/1997 | US5593875 Methods for calcium phosphate transfection |
| 01/14/1997 | US5593874 Dna for transgenic monocot plants and dna sequences |
| 01/14/1997 | US5593873 Vaccines |
| 01/14/1997 | US5593867 Fluorerscence polarization detection of nucleic acid amplication |
| 01/14/1997 | US5593866 Cationic peptides and method for production |
| 01/14/1997 | US5593864 Process for functional expression of the para cation channel |
| 01/14/1997 | US5593862 Nucleic acids encoding drosophila tipE cation channel proteins and recombinant expression of the same |
| 01/14/1997 | US5593861 Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins |
| 01/14/1997 | US5593860 Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids |
| 01/14/1997 | US5593858 Culturing host/vector pair where the host is selected from kluyveromyces |
| 01/14/1997 | US5593840 Also claimed: process for detecting enzymatically a mutation or an allele in a target nucleic acid sequence contained in nucleic acid/s/ |
| 01/14/1997 | US5593833 Bone disorders |
| 01/14/1997 | US5593827 N-(beta-ketocaproyl) homoserine lactone or analogue |
| 01/14/1997 | US5593825 Hepatitis B virus mutants, reagents and methods for detection |
| 01/14/1997 | US5593674 Coagulants |
| 01/14/1997 | US5593669 Pesticide, insecticide |
| 01/13/1997 | CA2181022A1 Cell-specific gene therapy using a novel promoter for tissue inhibitor of metalloproteinase-3 |
| 01/12/1997 | CA2180894A1 Sequencing near infrared and infrared fluorescence labeled dna for detecting using laser diodes and suitable labels therefore |
| 01/09/1997 | WO1997000972A1 Method and apparatus for determining a mutation |
| 01/09/1997 | WO1997000965A2 A lipidic vector for nucleic acid delivery |
| 01/09/1997 | WO1997000964A1 Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof |
| 01/09/1997 | WO1997000963A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | WO1997000962A1 A novel method to isolate mutants and to clone the complementing gene |
| 01/09/1997 | WO1997000961A1 Plant regulatory proteins iii |
| 01/09/1997 | WO1997000960A1 Novel human chemotactic cytokine |
| 01/09/1997 | WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | WO1997000958A1 NOVEL TGF-β LIKE CYTOKINE |
| 01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | WO1997000956A1 Hypoxia-responsive adhesion molecules, specific antibodies, and their uses |
| 01/09/1997 | WO1997000955A1 Human homolog of the mouse rab18 gene |
| 01/09/1997 | WO1997000954A1 C-cam expression constructs and their application in cancer therapy |
| 01/09/1997 | WO1997000953A1 Aortic preferentially-expressed gene apeg-1 and uses thereof |
| 01/09/1997 | WO1997000952A2 A human edg-2 receptor homolog |
| 01/09/1997 | WO1997000951A1 Dna encoding porcine complement inhibitor |
| 01/09/1997 | WO1997000950A1 New immunoregulatory protein lst-1 |
| 01/09/1997 | WO1997000947A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 01/09/1997 | WO1997000946A1 Immortalized epithelial tumor cell |
| 01/09/1997 | WO1997000945A1 Recombinant sweet protein mabinlin |
| 01/09/1997 | WO1997000944A1 Transformant producing substance pf1022 and method for transforming microorganism belonging to the class hyphomycetes |